相关实验视频

Updated: Jan 13, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

化学抗原受体T细胞疗法:不仅仅是一种抗癌药物

Hannah C M Schenk^1,2, Ilse Gille^2,3, Carolt Arana^4,5,6

¹Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.

|January 9, 2026

概括

化学抗原受体 (CAR) T细胞疗法显示出超越癌症的前景,通过精确准细胞来治疗自身免疫性疾病和感染. 需要进一步的研究,以解决更广泛应用的安全问题.

科学领域:

免疫治疗是一种免疫疗法.
细胞疗法细胞疗法
在瘤学瘤学.
这是一种自身免疫力.
病毒学病毒学
移植免疫学移植免疫学

背景情况:

化学抗原受体 (CAR) T细胞疗法最初针对血液恶性瘤的CD19和B细胞成熟抗原,取得了显著的成功.
卡尔T细胞疗法的应用已经扩展到B细胞介导的自身免疫性疾病,显示出长期症状缓解的潜力.
不选择性向B细胞需要开发精确的免疫疗法,能够区分致病性和保护性B细胞.

研究的目的:

审查CAR T细胞治疗在自身免疫,病毒学和移植方面的扩展应用.
突出抗原特异性CARs的发展,用于精确的细胞耗尽.
讨论CAR技术对监管T细胞 (Tregs) 的适应及其影响.

主要方法:

对CAR T细胞治疗应用现有文献的综述.
对抗原特异性CAR设计和包含自身抗原的修改CAR的讨论.
在各种疾病模型和临床环境中探索CAR T细胞和CAR Treg应用.

主要成果:

卡尔T细胞疗法在治疗B细胞介导的自身免疫性疾病和病毒感染方面表现出有效性.
抗原特异性CARs可以选择性地减少目标细胞亚群.
CAR Tregs具有诱导自身免疫性疾病,移植对宿主疾病和移植排斥的耐受性潜力.

结论:

CAR T细胞和CAR Treg疗法在治疗癌症以外的一系列疾病方面具有显著的前景.
对抗原特异性CARs和CAR Tregs的开发代表了精密免疫疗法的关键进步.
解决和解决与基于CAR的疗法相关的安全问题对于其广泛的临床采用至关重要.

关键词:

化学抗原受体 (CAR) 是一种化学抗原受体.这是自身免疫力.细胞疗法是细胞疗法.感染的感染感染.移植移植移植移植

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...